Journal article icon

Journal article

Biallelic variants in COPB1 cause a novel, severe intellectual disability syndrome with cataracts and variable microcephaly

Abstract:
BACKGROUND: Coat protein complex 1 (COPI) is integral in the sorting and retrograde trafficking of proteins and lipids from the Golgi apparatus to the endoplasmic reticulum (ER). In recent years, coat proteins have been implicated in human diseases known collectively as "coatopathies". METHODS: Whole exome or genome sequencing of two families with a neuro-developmental syndrome, variable microcephaly and cataracts revealed biallelic variants in COPB1, which encodes the beta-subunit of COPI (β-COP). To investigate Family 1's splice donor site variant, we undertook patient blood RNA studies and CRISPR/Cas9 modelling of this variant in a homologous region of the Xenopus tropicalis genome. To investigate Family 2's missense variant, we studied cellular phenotypes of human retinal epithelium and embryonic kidney cell lines transfected with a COPB1 expression vector into which we had introduced Family 2's mutation. RESULTS: We present a new recessive coatopathy typified by severe developmental delay and cataracts and variable microcephaly. A homozygous splice donor site variant in Family 1 results in two aberrant transcripts, one of which causes skipping of exon 8 in COPB1 pre-mRNA, and a 36 amino acid in-frame deletion, resulting in the loss of a motif at a small interaction interface between β-COP and β'-COP. Xenopus tropicalis animals with a homologous mutation, introduced by CRISPR/Cas9 genome editing, recapitulate features of the human syndrome including microcephaly and cataracts. In vitro modelling of the COPB1 c.1651T>G p. Phe551Val variant in Family 2 identifies defective Golgi to ER recycling of this mutant β-COP, with the mutant protein being retarded in the Golgi. CONCLUSIONS: This adds to the growing body of evidence that COPI subunits are essential in brain development and human health and underlines the utility of exome and genome sequencing coupled with Xenopus tropicalis CRISPR/Cas modelling for the identification and characterisation of novel rare disease genes.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s13073-021-00850-w
Publication website:
https://discovery.ucl.ac.uk/10181376/1/awad380-2.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0003-0612-5819
More by this author
Role:
Author
ORCID:
0000-0001-5264-7824
More by this author
Role:
Author
ORCID:
0000-0002-0494-0783
More by this author
Role:
Author
ORCID:
0000-0002-3255-7044
More by this author
Role:
Author
ORCID:
0000-0002-8458-5581


More from this funder
Funder identifier:
10.13039/501100000272
Grant:
RP-2016-07-011
More from this funder
Funder identifier:
10.13039/501100000268
Grant:
BB/K019988/1
More from this funder
Funder identifier:
10.13039/100004440
Grant:
101480Z


Publisher:
BioMed Central
Journal:
Genome Medicine More from this journal
Volume:
13
Issue:
1
Pages:
34-34
Article number:
34
Publication date:
2021-02-25
DOI:
EISSN:
1756-994X
ISSN:
1756-994X


Language:
English
Keywords:
Pubs id:
1532778
Local pid:
pubs:1532778
Source identifiers:
W3130792055
Deposit date:
2026-05-17
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP